MiniMed wins quick FDA clearance for Fit patch pump

After submitting its patch pump for FDA review in late August, MiniMed (Nasdaq: MMED) has turned around a quick clearance for the Fit automated insulin delivery system.

The Fit marks the company’s first tubeless design, carrying a 300-unit insulin capacity and a seven-day wear time that does not require recharging or cartridge changes.

For continuous glucose monitor compatibility, the waterproof wearable is set to launch next year with links to MiniMed’s seven-day Simplera Sync as well as the 15-day Instinct sensor made for the company by Abbott. The patch pump will also be controlled by iOS and Android smartphone apps.

Sign up for Blog Updates